PharmaCyte Biotech Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
16 Jun 23 | SellUS$17,877 | Iroquois Capital Management, LLC | Company | 5,900 | US$3.03 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 192,140 | 2.27% |
Individual Insiders | 199,527 | 2.36% |
Institutions | 1,275,644 | 15.1% |
General Public | 6,786,085 | 80.3% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
304,613 | US$644.4k | 17.9% | 0.39% | |||
215,637 | US$456.2k | -1.59% | no data | |||
189,350 | US$400.6k | 0% | 38.96% | |||
174,602 | US$369.4k | 1.91% | no data | |||
140,265 | US$296.7k | -87.3% | no data | |||
82,727 | US$175.0k | -75% | no data | |||
82,727 | US$175.0k | 0% | 0.32% | |||
82,373 | US$174.3k | -15.2% | 1.01% | |||
50,000 | US$105.8k | 0% | no data | |||
50,000 | US$105.8k | 0% | no data | |||
50,000 | US$105.8k | 0% | no data | |||
41,188 | US$87.1k | 87% | no data | |||
38,100 | US$80.6k | 15.8% | no data | |||
28,618 | US$60.5k | -19.1% | no data | |||
24,563 | US$52.0k | -16.2% | no data | |||
23,200 | US$49.1k | -0.43% | no data | |||
21,104 | US$44.6k | -26.6% | no data | |||
19,283 | US$40.8k | 0% | no data | |||
14,846 | US$31.4k | 0% | no data | |||
10,400 | US$22.0k | 0% | no data | |||
5,947 | US$12.6k | 0% | no data | |||
3,598 | US$7.6k | 0% | no data | |||
3,589 | US$7.6k | -25.1% | no data | |||
2,802 | US$5.9k | 0.04% | no data | |||
1,875 | US$4.0k | 53.9% | no data |